Publication | Closed Access

Bruton’s tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells

InflammationImiquimod-induced Psoriasis-like InflammationCytokineImmunologyImmune RegulationChronic InflammationImmune SystemImmune-mediated Inflammatory DiseasesInnate ImmunityDermatologyImmunotherapyMedicineInflammatory DiseaseTyrosine Kinase InhibitorBruton ’